Introduction Children admitted to paediatric and neonatal intensive care units may be at high
risk from medication errors and preventable adverse drug events. Objective The objective of …

Until recently, it was considered unethical or impossible to perform clinical trials of new
medicines in children. As a consequence, many medicines used for treating children are …

Objective: To determine the extent of use of unlicensed and off label drugs in children in
hospital in five European countries. Design: Prospective study of drugs administered to …

The aim was to compare results of studies performed in different settings worldwide and
identify common therapeutic areas to allow for focused interventions, because off-label drug …

To determine the incidence of adverse drug reactions (ADRs) to unlicensed and off‐label
drugs used in paediatric inpatients, we carried out prospective surveillance on five different …

Aims To investigate the potential relationship between off-label drug use and increased risk
of adverse drug reactions in paediatric outpatients. Methods A prospective …

Objective: To determine the extent of use in children in hospital of drugs that are not
specifically licensed for use in children (unlicensed) and of drugs that are used outside the …

This review aims to give an updated overview of the worldwide situation of off-label and
unlicensed drug use in the paediatric field, also taking into account the safety of this kind of …

AIM To determine the extent of use of drugs that are either not licensed (unlicensed), or are
outside the terms of their product licence (off label) in a neonatal intensive care unit …

Objective: To assess whether the clinical experience of undergraduate medical students
relates to their performance in final examinations and whether learning styles relate either to …